Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 29, 2015 9:15 AM ET

Biotechnology

Company Overview of Mirna Therapeutics, Inc.

Company Overview

Mirna Therapeutics, Inc. operates as a biopharmaceutical company that develops microRNA-based oncology therapeutics. It offers MRX34 to deliver a mimic of the naturally occurring microRNA tumor suppressor, miR-34, which is lost or under expressed in tumors of patients with various cancers, including cervical cancer, ovarian cancer, glioblastoma, hepatocellular carcinoma (liver cancer), colon cancer, non-small cell lung cancer, and in cancer stem cells. The company was founded in 2007 and is based in Austin, Texas. Mirna Therapeutics, Inc. operates as a subsidiary of Asuragen, Inc.

2150 Woodward Street

Suite 100

Austin, TX 78744

United States

Founded in 2007

Phone:

512-901-0900

Fax:

512-681-5201

Key Executives for Mirna Therapeutics, Inc.

Chief Executive Officer, President and Director
Age: 56
Founder, Executive Chairman and Chief Scientific Officer
Chief Financial Officer
Senior Vice President and General Counsel
Chief Medical Officer and Vice President of Oncology
Compensation as of Fiscal Year 2014.

Mirna Therapeutics, Inc. Key Developments

Mirna Therapeutics, Inc. Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 12:00 PM

Mirna Therapeutics, Inc. Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 12:00 PM. Venue: Hyatt Chicago Magnificent Mile, Chicago, Illinois, United States.

Mirna Therapeutics, Inc. Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 03:30 PM

Mirna Therapeutics, Inc. Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 03:30 PM. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Zurich, Switzerland.

Mirna Therapeutics, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 10:40 AM

Mirna Therapeutics, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 10:40 AM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: Paul Lammers, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
Principio, Inc. United States
VLST Corporation United States
allvivo, Inc. United States
PharmaGenoma, Inc. United States
Amplimmune, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
March 31, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mirna Therapeutics, Inc., please visit www.mirnatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.